Study on the health effects of early menopause
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with premature ovarian insufficiency (POI) before age 40.
- Your diagnosis meets one of these: irregular or no periods for at least 4 months with high FSH, or you had both ovaries removed, or you had ovarian failure from chemotherapy or radiation.
- You are willing to give blood or other samples and come back for regular check-ups over time.
- You are not pregnant or breastfeeding right now.
- You do not have a serious illness like active cancer, severe heart or kidney disease, or a condition that would make it hard to follow the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a Chinese herbal medicine called Huanjingjian Decoction to see if it helps women with premature ovarian insufficiency (early menopause) have more regular periods and improve hormone levels. If you are under 40 and have this condition, this treatment might help you.
This study looks at the genes that may cause premature ovarian insufficiency (POI), a condition where the ovaries stop working before age 40. The researchers will compare the genes of women with POI to those with normal ovarian function, which may lead to better understanding and future treatments.
This trial tests whether hormone replacement therapy (HRT) helps protect bone health in teenagers with premature ovarian insufficiency (POI). It compares HRT to a placebo and also includes healthy volunteers for comparison.
This study looks at how certain blood markers relate to ovarian function in women with normal ovaries, diminished ovarian reserve (DOR), or primary ovarian insufficiency (POI). It may help doctors better understand these conditions.
This trial tests whether a hormone injection called HCG can activate dormant egg follicles in women under 40 who have gone through premature ovarian insufficiency (POI). If successful, it may help these women conceive.
This trial tests a medicine called finerenone to see if it can help women with premature ovarian insufficiency (early menopause). It may help restore ovarian function and improve quality of life.
Hear when a new Premature Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.